Award
Delivery Order #SPE2D226F1364
Delivery Order for Moxifloxacin Hydrocortisone under Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$17.91
Ceiling
$17.91
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Feb 26, 2026
Identifier
SPE2D226F1364
NAICS
325411
This award is a delivery order contract, issued under a larger indefinite delivery contract (IDV) for pharmaceutical supplies. The recipient is DMS Pharmaceutical Group Inc., a well-established pharmaceutical manufacturer and distributor specializing in providing essential medications to government agencies. The specific product procured under this delivery order is moxifloxacin hydrocortisone, a critical pharmaceutical agent likely used to treat infections and inflammation. This award is significant as it supports the government's ongoing effort to maintain an uninterrupted supply of vital medications, thereby strengthening public health systems. The scope encompasses the delivery of this specific drug to the designated location in Park Ridge, Illinois, reflecting a targeted and timely fulfillment of a pharmaceutical need. The larger IDV contract, awarded competitively, ensures sustained and reliable pharmaceutical provision over multiple years. This delivery order represents a multi-year agreement fulfilled within a short timeframe, supporting urgent or scheduled healthcare demands.
Description
8511947075!MOXIFLOXACIN HYDROC